Filter by: patients
What is Salsalate?

Salsalate is a salicylate used in the treatment of minor pain or fever and arthritis.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Arthritis pain 8 2 Efficacy_moderate Efficacy_slight
Pain 6 1 Efficacy_slight
Inflammation in joints 3 1 Efficacy_none
Other 2 0
Fibromyalgia 2 1 Efficacy_moderate
Inflammation 1 0

See all 18 patients currently taking Salsalate

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
1
Moderate
0
Mild
1
None
3

Reported Dosages

  750 as needed 750mg as needed 500 mg daily 1,000 mg daily 1,500 mg daily 2,000 mg daily 2,250 mg daily 3,000 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 3 Number of Patients: 3 2 Number of Patients: 2 1 Number of Patients: 1 2 Number of Patients: 2 6 Number of Patients: 6  

Reported Stop Reasons

Why Patients Stopped Taking Salsalate (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 2   Did not seem to work: 40%
Side effects too severe 2   Side effects too severe: 40%

See all 4 patients who’ve stopped taking Salsalate

Currently Taking Salsalate

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Stopped Taking Salsalate

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Salsalate

Always
3 60%
Usually
1 20%
Sometimes
1 20%
Never
0 0%

Burden

Difficulty being on treatment

Burden of Salsalate

Very
0 0%
Somewhat
1 20%
A little
0 0%
Not at all
4 80%

Cost

Paid out of pocket

Cost of Salsalate

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
4 100%

See more information, including instructions, precautions, side effects, and interactions.

Report created on February 12, 2012.